Prognostic value of plasminogen activators and their inhibitors in colorectal cancer
- 31 August 1995
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (7-8) , 1105-1109
- https://doi.org/10.1016/0959-8049(95)00170-n
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasisGastroenterology, 1994
- Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancerThe Lancet, 1994
- Urokinase receptor and colorectal cancer survivalThe Lancet, 1994
- Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomasBritish Journal of Cancer, 1994
- The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancerInternational Journal of Cancer, 1992
- Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasiaGastroenterology, 1991
- Immunolocalization of urokinase‐type plasminogen activator in adenomas and carcinomas of the colorectumHistopathology, 1991
- Clinical Relevance of the Urokinase-Type and Tissue-Type Plasminogen Activators and of Their Type 1 Inhibitor in Breast CancerSeminars in Thrombosis and Hemostasis, 1991
- Plasminogen activators in (pre)malignant conditions of the colorectumEuropean Journal of Cancer and Clinical Oncology, 1989
- Plasminogen Activators, Tissue Degradation, and CancerPublished by Elsevier ,1985